Aethlon director forfeits shares for tax withholding

Aethlon Medical Inc. director Chetan Shah reported a routine tax-related share forfeiture tied to equity compensation.

Rhea-AI Filing Summary

Aethlon Medical Inc. director Chetan Shah reported a routine tax-related share forfeiture tied to equity compensation. On this Form 4, he forfeited 2,182 shares of common stock to cover tax withholdings when 5,454 vested restricted stock units converted into common shares.

The forfeiture was priced using the issuer’s market price of $0.82 per share at the time. Following this tax-withholding disposition, Shah directly holds 20,840 shares of Aethlon Medical common stock, reflecting his continuing equity stake after the RSU vesting event.

Insider Trade Summary

Exercise Price or Tax Liability: 2,182 shares

Exercise Price or Tax Liability 1 txn

Insider Shah Chetan

Role Director

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	2,182	$0.82	$2K

Holdings After Transaction: Common Stock — 20,840 shares (Direct)

Footnotes (1)

1. F1. The Reporting Person forfeited 2,182 shares of common stock upon conversion of an aggregate 5,454 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 17, 2026.

Key Figures

Shares forfeited for tax withholding: 2,182 shares Market price at forfeiture: $0.82 per share Vested RSUs converted: 5,454 units +1 more

4 metrics

Shares forfeited for tax withholding 2,182 shares Tax-withholding disposition on RSU conversion

Market price at forfeiture $0.82 per share Used to value 2,182 forfeited shares

Vested RSUs converted 5,454 units Restricted stock units converting into common stock

Shares held after transaction 20,840 shares Direct common stock holdings following tax forfeiture

Key Terms

restricted stock units, tax withholdings, forfeited, tax-withholding disposition

4 terms

restricted stock units financial

"These restricted stock units were part of the grant reported in Table I"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholdings financial

"to cover tax withholdings, using the market price of the issuer's common stock"

forfeited financial

"The Reporting Person forfeited 2,182 shares of common stock upon conversion"

tax-withholding disposition financial

"transaction_action: "tax-withholding disposition""

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Aethlon Medical (AEMD) director Chetan Shah report?

Director Chetan Shah reported forfeiting 2,182 Aethlon Medical common shares to cover tax obligations. The forfeiture occurred when 5,454 vested restricted stock units converted into common stock, and is classified as a tax-withholding disposition rather than an open-market sale.

How many Aethlon Medical (AEMD) shares did Chetan Shah forfeit for taxes?

Chetan Shah forfeited 2,182 shares of Aethlon Medical common stock to satisfy tax withholdings. The shares were valued using the issuer’s $0.82 market price at the time of forfeiture, in connection with the conversion of 5,454 vested restricted stock units.

How many Aethlon Medical (AEMD) RSUs vested for Chetan Shah in this Form 4?

An aggregate 5,454 vested and outstanding restricted stock units converted into Aethlon Medical common shares for Chetan Shah. As part of this vesting event, 2,182 of the resulting shares were forfeited to cover tax withholdings based on the prevailing market price.

Is Chetan Shah’s Aethlon Medical (AEMD) transaction a stock sale?

The transaction is not an open-market stock sale; it is a tax-withholding disposition. Shah forfeited 2,182 shares that arose from 5,454 vested restricted stock units to pay taxes due, a common mechanism for handling equity compensation tax obligations.

What are Chetan Shah’s Aethlon Medical (AEMD) holdings after this Form 4 event?

After the reported tax-withholding forfeiture, Chetan Shah directly holds 20,840 shares of Aethlon Medical common stock. This figure reflects his position following the conversion of 5,454 restricted stock units and the forfeiture of 2,182 shares to cover associated tax liabilities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/01/2026 - 05:16 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shah Chetan

(Last) (First) (Middle)

11555 SORRENTO VALLEY RD, STE 203

(Street)

SAN DIEGO CALIFORNIA 92121

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AETHLON MEDICAL INC [ AEMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/30/2026		F		2,182(1)	D	$0.82	20,840	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Reporting Person forfeited 2,182 shares of common stock upon conversion of an aggregate 5,454 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 17, 2026.

	/s/ Chetan Shah, by: James B. Frakes, Attorney-in-fact	07/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)